Abstract Background and Aims Several widely used medications, with a relevant efficacy
profile, are toxic to the peripheral nervous system and an even larger number of agents are …

The peripheral nervous system can encounter alterations due to exposure to some of the
most commonly used anticancer drugs (platinum drugs, taxanes, vinca alkaloids …

Purpose Clinical practice guidelines recommend altering neurotoxic chemotherapy
treatment in patients experiencing intolerable chemotherapy-induced peripheral neuropathy …

Chemotherapy-induced peripheral neuropathy (CIPN) is a major challenge for cancer
patients who undergo chemotherapy with paclitaxel. Therefore, finding effective therapies for …

Gait analysis could be used in animal models as an indicator of sensory ataxia due to
chemotherapy-induced peripheral neurotoxicity (CIPN). Over the years, gait analysis in in …

Radiation‐induced brachial plexopathy (RIBP) is an iatrogenic, progressively disabling, and
often very late effect of adjuvant radiotherapy most commonly seen in breast cancer …

Objective To define the incidence and risk factors for developing chemotherapy‐induced
neuropathic pain (CINP). Methods Retrospective, file‐based analysis on cancer patients …

Despite the considerable advancements in chemotherapy as a cornerstone modality in
cancer treatment, the prevalence of complications and pre-existing diseases is on the rise …

Abstract Background and Aims Chemotherapy‐induced peripheral neurotoxicity (CIPN) is a
common and long‐lasting adverse event of several anticancer compounds, for which …

Paclitaxel-induced peripheral neurotoxicity (PIPN) is a potentially dose-limiting side effect in
anticancer chemotherapy. Several animal models of PIPN exist, but their results are …